Genotyping Assay Market was valued at USD 5.1 Billion in 2022 and is projected to reach USD 9.6 Billion by 2030, growing at a CAGR of 8.5% from 2024 to 2030.
Looking forward, the period from 2023 to 2033 is expected to witness even more significant growth, as advancements in CRISPR gene editing, artificial intelligence in genomics, and the emergence of more affordable sequencing technologies continue to shape the market. By 2033, the genotyping assay market is forecast to grow at a CAGR of 15%, with a major increase in demand driven by genetic testing for non-invasive prenatal diagnostics, disease prevention, and the customization of treatments based on individual genetic profiles.
The demand from clinical diagnostics, drug discovery, and agriculture will play a pivotal role in driving the market forward. Furthermore, the increasing awareness around the importance of genetic testing for early detection of diseases, as well as the push towards personalized healthcare solutions, will continue to fuel demand. Genotyping assays are also becoming essential tools in personalized oncology, where genetic testing allows clinicians to determine the most effective treatment plans for patients.
Technological innovations will remain at the heart of this market’s growth. From more efficient high-throughput screening methods to improved bioinformatics tools for analyzing complex genetic data, the 2023-2033 period is expected to see numerous breakthroughs that will make genotyping assays more accessible, faster, and more affordable. Market players are expected to introduce multi-omics approaches, combining genotyping with other genomic testing methods, to meet the diverse demands of researchers and healthcare providers.
Get an In-Depth Research Analysis of the Global Genotyping Assay Market Size And Forecast [2025-2032]
The genotyping assay market, which witnessed significant growth between 2018 and 2022, is now poised for continued expansion in the coming decade. With advancements in genetic research, increased demand for personalized medicine, and rising applications in agriculture and forensics, the global genotyping assay market has evolved considerably. In the 2018-2022 period, the market was largely driven by the integration of next-generation sequencing (NGS) technologies and the growing need for precise genetic screening in medical diagnostics.
During these years, key players in the market focused on enhancing the accuracy and efficiency of genotyping assays, which led to a surge in product innovations. This period also saw a rise in the adoption of genotyping assays in pharmacogenomics, cancer research, and rare disease diagnostics. Market analysts estimated that by 2022, the genotyping assay market had grown at a compound annual growth rate (CAGR) of around 12%, largely fueled by advancements in genomic technologies and increasing investments in research and development.
Illumina
Thermo Fisher Scientific
Roche
Qiagen N.V.
Agilent
Fluidigm
Genewiz
Integrated Dna Technologies
Perkinelmer
Bio-Rad Laboratories
Eurofins Scientific
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Genotyping Assay Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Genotyping Assay Market
Pharmacogenomics
Diagnostic Research
Animal Genetics
Agricultural Biotechnology
Others
Based on Types the Market is categorized into Below types that held the largest Genotyping Assay market share In 2023.
PCR
Sequencing
Microarray
Others
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Genotyping Assay Market Research Analysis
1. Introduction of the Global Genotyping Assay Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Genotyping Assay Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Genotyping Assay Market, By Type
6. Global Genotyping Assay Market, By Application
7. Global Genotyping Assay Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Genotyping Assay Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/